Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M52,484Revenue $M104,099Net Margin (%)1.8Z-Score3.1
Enterprise Value $M64,428EPS $2.3Operating Margin %3.4F-Score5
P/E(ttm))30.4Cash Flow Per Share $3.6Pre-tax Margin (%)2.9Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %25.9Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %24.3Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow14.9y-y EBITDA Growth Rate %9.2ROA % (ttm)3.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.5Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M814ROI % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXVanguard Health Care Fund 2014-03-31 Buy 0.69%$69.84 - $78.64
($74.72)
$ 67.8-9%New holding, 3265000 sh.3,265,000
ESRXDodge & Cox 2014-03-31 Add0.46%$69.84 - $78.64
($74.73)
$ 67.8-9%Add 106.54%11,586,300
ESRXMario Gabelli 2014-03-31 Add0.05%$69.84 - $78.64
($74.73)
$ 67.8-9%Add 60.44%316,403
ESRXGlenn Greenberg 2014-03-31 Reduce-1.19%$69.84 - $78.64
($74.73)
$ 67.8-9%Reduce -10.42%3,546,006
ESRXRay Dalio 2014-03-31 Reduce-0.02%$69.84 - $78.64
($74.73)
$ 67.8-9%Reduce -30%99,888
ESRXGlenn Greenberg 2013-12-31 Add1.67%$60.88 - $70.6
($65.26)
$ 67.84%Add 17.2%3,958,387
ESRXScott Black 2013-12-31 Add0.74%$60.88 - $70.6
($65.26)
$ 67.84%Add 130.81%173,883
ESRXWallace Weitz 2013-12-31 Add0.48%$60.88 - $70.6
($65.26)
$ 67.84%Add 20.62%1,184,825
ESRXDodge & Cox 2013-12-31 Buy 0.41%$60.88 - $70.6
($65.26)
$ 67.84%New holding, 5609705 sh.5,609,705
ESRXMario Gabelli 2013-12-31 Add0.01%$60.88 - $70.6
($65.26)
$ 67.84%Add 24.35%197,214
ESRXLee Ainslie 2013-12-31 Sold Out -3.5%$60.88 - $70.6
($65.26)
$ 67.84%Sold Out0
ESRXLeon Cooperman 2013-12-31 Reduce-1.64%$60.88 - $70.6
($65.26)
$ 67.84%Reduce -90.9%173,100
ESRXJoel Greenblatt 2013-12-31 Reduce-0.11%$60.88 - $70.6
($65.26)
$ 67.84%Reduce -61.22%34,242
ESRXRay Dalio 2013-12-31 Reduce-0.04%$60.88 - $70.6
($65.26)
$ 67.84%Reduce -34.72%142,688
ESRXLee Ainslie 2013-09-30 Add2.22%$60.94 - $67.66
($64.76)
$ 67.85%Add 173.46%4,184,162
ESRXScott Black 2013-09-30 Buy 0.53%$60.94 - $67.66
($64.76)
$ 67.85%New holding, 75336 sh.75,336
ESRXJoel Greenblatt 2013-09-30 Buy 0.18%$60.94 - $67.66
($64.76)
$ 67.85%New holding, 88295 sh.88,295
ESRXMario Gabelli 2013-09-30 Add0.04%$60.94 - $67.66
($64.76)
$ 67.85%Add 202.84%158,598
ESRXRay Dalio 2013-09-30 Add0.04%$60.94 - $67.66
($64.76)
$ 67.85%Add 62.78%218,588
ESRXGlenn Greenberg 2013-09-30 Reduce-2.34%$60.94 - $67.66
($64.76)
$ 67.85%Reduce -19.48%3,377,491
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ESRX Vanguard Health Care Fund 2014-03-313,265,0000.40.69New Buy
ESRX Dodge & Cox 2014-03-3111,586,3001.420.89+106.54%
ESRX Mario Gabelli 2014-03-31316,4030.040.13+60.44%
ESRX Wallace Weitz 2014-03-311,210,9050.152.9+2.2%
ESRX Jean-Marie Eveillard 2014-03-311,16800
ESRX Scott Black 2014-03-31167,4140.021.4-3.72%
ESRX John Keeley 2014-03-3132,87900.04-4.11%
ESRX Ruane Cunniff 2014-03-315,65500-5.07%
ESRX Glenn Greenberg 2014-03-313,546,0060.4410.8-10.42%
ESRX Joel Greenblatt 2014-03-3127,97100.03-18.31%
ESRX Leon Cooperman 2014-03-31141,3000.020.14-18.37%
ESRX Ray Dalio 2014-03-3199,8880.010.06-30%
Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAZ GEORGEChairman & CEO 2014-06-13Sell681,508$71.21-5.25view
WENTWORTH TIMOTHY CPresident 2014-05-27Sell105,677$70.47-4.26view
Wimberly GarySr. VP & Ch. Information Off. 2014-03-13Sell44,497$78.41-13.95view
Houston ChristineSr. Vice President, Operations 2014-03-12Sell19,757$78.53-14.08view
IGNACZAK EDWARD BExec. VP, Sales and Mktg 2014-03-11Sell120,247$78.54-14.09view
Norton David ASenior VP, Supply Chain 2014-03-11Sell3,160$79.15-14.76view
Ebling Keith J.Exec. VP and Gen. Counsel 2014-03-11Sell25,721$78.69-14.26view
Miller Steven BSr. VP & Chief Med. Officer 2014-03-10Sell12,664$77.96-13.46view
McNamee PatrickExec. VP and COO 2014-03-10Sell68,425$78.28-13.81view
Ebling Keith J.Exec. VP and Gen. Counsel 2014-03-07Sell295,367$77.29-12.71view

Press Releases about ESRX :

    Quarterly/Annual Reports about ESRX:

    News about ESRX:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Installed Building Products Inc, Express Scripts, Adobe Systems Inc, and Jun 22 2014 
    Wedgewood Partners' David Rolfe's Top Five Stocks May 28 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
    Warrior Capital’s Major Sells in Review - VistaPrint, Google, Fiserv, Express Scripts Nov 30 2013 
    Scott Black's Top 5 New Stock Buys Oct 21 2013 
    Richard Perry – Eight Sells in Second Quarter – MGIC Up 505% Aug 24 2013 
    ESRX Has More Upside Potential Than You Might Expect Jul 01 2013 
    Trust, But Verify Jun 23 2013 
    4 Stocks Leon Cooperman Is Buying Jun 19 2013 


    More From Other Websites
    How Gilead Sciences Can Deliver A Double: Part Two Jul 11 2014
    A year of winners (and losers) post-'Alpha' Jul 11 2014
    Market Rarity: Great Company At Very Good Price Jul 09 2014
    Mid-Year Report Part 2: Not All Stocks Overpriced Jul 09 2014
    Express Scripts (ESRX): Moving Average Crossover Alert Jul 09 2014
    [video] Newspaper Readership Then, Now and in the Future Jul 08 2014
    Express Scripts Holding Company Announces Second Quarter 2014 Earnings Conference Call Jul 07 2014
    Express Scripts Holding Company Announces Second Quarter 2014 Earnings Conference Call Jul 07 2014
    Growth-Centrism Is Flawed Jul 06 2014
    Walgreen, Rite Aid Comp Sales Beat On Pharmacies Jul 03 2014
    Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000 Jul 03 2014
    3 Stocks Pushing The Health Care Sector Higher Jul 03 2014
    Express Scripts cuts payments for customized drugs Jul 03 2014
    Express Scripts cuts payments for customized drugs Jul 03 2014
    The Market's So Strong Even Its Biggest Losers are Winning Jul 01 2014
    Express Scripts to restrict coverage on compounded medecines, WSJ says Jul 01 2014
    Express Scripts Names David Queller Senior Vice President, Sales and Account Management Jul 01 2014
    Express Scripts Names David Queller Senior Vice President, Sales and Account Management Jul 01 2014
    Stock-Picking Increasingly Critical in Health Care Jun 28 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide